Trends in biomarker discoveries for the early detection and risk stratification of pancreatic cancer using omics studies

Expert Rev Mol Diagn. 2019 Aug;19(8):651-654. doi: 10.1080/14737159.2019.1643718. Epub 2019 Jul 17.

Authors

Takashi Kobayashi¹, Kazufumi Honda²

Affiliations

¹ Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine , Kobe , Hyogo , Japan.
² Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute , Tokyo , Japan.

PMID: 31298060
DOI: 10.1080/14737159.2019.1643718

No abstract available

Keywords: Biomarker; apolipoprotein A2 isoforms; cancer screening; pancreatic cancer; risk stratification.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / genetics*
Early Detection of Cancer
Genomics*
Humans
Pancreatic Neoplasms / diagnosis*
Pancreatic Neoplasms / genetics
Risk Assessment

Substances

Biomarkers, Tumor